This activity is expired and is no longer available for CME credit.


Redefining the Role of Photodynamic Therapy in Neovascular Age-related Macular Degeneration

Author(s)/Faculty: Scott W. Cousins, MD; Gregg T. Kokame, MD, MMM
Release Date: 3/5/2016Expiration Date: 3/4/2017
Credit Type: CMENumber of Credits: 0
Content Type: LectureProvider:
Photodynamic therapy (PDT), with use of verteporfin as a photosensitizer, is one of the few therapies that has been shown to effectively slow the progression of the "wet" form of age-related macular degeneration (AMD), and even to stabilize visual acuity over many years. Polypoidal choroidal vasculopathy (PCV) can be difficult to distinguish from AMD. High-speed laser video indocyanine green (ICG) angiography can be critical in the identification of an occult choroidal neovascular (CNV) membrane and in the diagnosis of polypoidal choroidal vasculopathy (PCV). This CME activity will provide an update on the features of PCV, the utility of PDT to treat this disease, and the place it continues to occupy in the AMD treatment armamentaria.